Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amicus Therapeutics

6.21
+0.23003.85%
Post-market: 6.210.00000.00%16:37 EDT
Volume:6.70M
Turnover:41.61M
Market Cap:1.91B
PE:-64.60
High:6.31
Open:6.17
Low:6.09
Close:5.98
Loading ...
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities